Display options
Share it on

J Biol Chem. 2010 Mar 26;285(13):10005-10015. doi: 10.1074/jbc.M109.093666. Epub 2010 Jan 27.

Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant.

The Journal of biological chemistry

Rui-Zhu Zhang, Yaqun Zou, Te-Cheng Pan, Dessislava Markova, Andrzej Fertala, Ying Hu, Stefano Squarzoni, Umbertina Conti Reed, Suely K N Marie, Carsten G Bönnemann, Mon-Li Chu

Affiliations

  1. Departments of Dermatology and Cutaneous Biology, Philadelphia, Pennsylvania 19107.
  2. Division of Neurology, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104.
  3. Institute of Molecular Genetics-National Research Council, Unit of Bologna, 40136 Bologna, Italy.
  4. Departamento de Neurologia, Faculdade de Medicina da Universidade de Sao Paulo, O5403-000 Sao Paulo SP, Brazil.
  5. Departments of Dermatology and Cutaneous Biology, Philadelphia, Pennsylvania 19107; Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107. Electronic address: [email protected].

PMID: 20106987 PMCID: PMC2843164 DOI: 10.1074/jbc.M109.093666

Abstract

Ullrich congenital muscular dystrophy (UCMD) is a disabling and life-threatening disorder resulting from either recessive or dominant mutations in genes encoding collagen VI. Although the majority of the recessive UCMD cases have frameshift or nonsense mutations in COL6A1, COL6A2, or COL6A3, recessive structural mutations in the COL6A2 C-globular region are emerging also. However, the underlying molecular mechanisms have remained elusive. Here we identified a homozygous COL6A2 E624K mutation (C1 subdomain) and a homozygous COL6A2 R876S mutation (C2 subdomain) in two UCMD patients. The consequences of the mutations were investigated using fibroblasts from patients and cells stably transfected with the mutant constructs. In contrast to expectations based on the clinical severity of these two patients, secretion and assembly of collagen VI were moderately affected by the E624K mutation but severely impaired by the R876S substitution. The E624K substitution altered the electrostatic potential of the region surrounding the metal ion-dependent adhesion site, resulting in a collagen VI network containing thick fibrils and spots with densely packed microfibrils. The R876S mutation prevented the chain from assembling into triple-helical collagen VI molecules. The minute amount of collagen VI secreted by the R876S fibroblasts was solely composed of a faster migrating chain corresponding to the C2a splice variant with an alternative C2 subdomain. In transfected cells, the C2a splice variant was able to assemble into short microfibrils. Together, the results suggest that the C2a splice variant may functionally compensate for the loss of the normal COL6A2 chain when mutations occur in the C2 subdomain.

References

  1. J Biol Chem. 2003 Apr 25;278(17):15326-32 - PubMed
  2. Thromb Haemost. 2004 Dec;92(6):1377-86 - PubMed
  3. EMBO J. 1989 Jul;8(7):1939-46 - PubMed
  4. Ann Neurol. 2008 Sep;64(3):294-303 - PubMed
  5. J Biol Chem. 1998 Mar 27;273(13):7423-30 - PubMed
  6. Neurology. 2008 Jul 29;71(5):312-21 - PubMed
  7. J Med Genet. 2005 Sep;42(9):673-85 - PubMed
  8. J Biol Chem. 2008 Apr 18;283(16):10658-70 - PubMed
  9. Eur J Biochem. 1994 Apr 1;221(1):177-85 - PubMed
  10. Structure. 1997 Sep 15;5(9):1147-56 - PubMed
  11. Hum Mutat. 2008 Jun;29(6):809-22 - PubMed
  12. Hum Mol Genet. 2005 Jan 15;14(2):279-93 - PubMed
  13. J Med Genet. 2005 Feb;42(2):108-20 - PubMed
  14. J Biol Chem. 2008 Jul 18;283(29):20170-80 - PubMed
  15. Neurology. 2008 Oct 14;71(16):1245-53 - PubMed
  16. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7516-21 - PubMed
  17. J Biol Chem. 1990 Apr 15;265(11):6473-80 - PubMed
  18. FASEB J. 2000 Apr;14(5):761-8 - PubMed
  19. Mol Biol Cell. 2002 Oct;13(10):3369-87 - PubMed
  20. Ann Neurol. 2001 Aug;50(2):261-5 - PubMed
  21. J Biol Chem. 1998 Apr 24;273(17):10396-401 - PubMed
  22. Am J Hum Genet. 2002 Jun;70(6):1446-58 - PubMed
  23. Mol Cell Neurosci. 2005 Nov;30(3):408-17 - PubMed
  24. J Biol Chem. 2002 Nov 15;277(46):43557-64 - PubMed
  25. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1873-8 - PubMed
  26. Am J Hum Genet. 2003 Aug;73(2):355-69 - PubMed
  27. EMBO J. 1990 Feb;9(2):385-93 - PubMed
  28. Neurology. 2002 Feb 26;58(4):593-602 - PubMed
  29. Blood. 1998 Mar 15;91(6):2032-44 - PubMed
  30. Ann Neurol. 2005 Sep;58(3):400-10 - PubMed
  31. Hum Mol Genet. 1998 May;7(5):807-12 - PubMed
  32. Ann Neurol. 2007 Oct;62(4):390-405 - PubMed
  33. Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13062-7 - PubMed
  34. Neuromuscul Disord. 2004 Oct;14(10):635-49 - PubMed
  35. Cell. 1995 Feb 24;80(4):631-8 - PubMed
  36. EMBO J. 1992 Dec;11(12):4281-90 - PubMed
  37. Immunol Rev. 2002 Aug;186:141-63 - PubMed
  38. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10277-81 - PubMed
  39. J Mol Biol. 1982 Jun 5;157(4):671-9 - PubMed

Substances

MeSH terms

Publication Types

Grant support